Abstract Submission

EWMA-DEWU 2026

Welcome to the abstract submission for EWMA-DEWU 2026

The abstract submission will open in August 2025

International abstract submission
Abstracts submitted in English are evaluated by the EWMA Scientific Committee and considered for the English spoken programme.
Submission deadline: 4 December 2025, 23:59 CET

German abstract submission
Abstracts submitted in German are evaluated by the DEWU Scientific Committee and considered for the German spoken programme.
Submission deadline: 4 December 2025, 23:59 CET

NB! Please note that you cannot submit your abstract in one language and present it in the other.

Notification of acceptance or rejection will be sent to all submitters in February 2026.

Questions can be addressed to scientific@ewma.org.

Welcome to the abstract submission for EWMA-DEWU 2026

The abstract submission will open in August 2025

International abstract submission
Abstracts submitted in English are evaluated by the EWMA Scientific Committee and considered for the English spoken programme.
Submission deadline: 4 December 2025, 23:59 CET

German abstract submission
Abstracts submitted in German are evaluated by the DEWU Scientific Committee and considered for the German spoken programme.
Submission deadline: 4 December 2025, 23:59 CET

NB! Please note that you cannot submit your abstract in one language and present it in the other.

Notification of acceptance or rejection will be sent to all submitters in February 2026.

Questions can be addressed to scientific@ewma.org.

IMPORTANT DATES

Abstract presentation types

Submit your abstract for:

Oral Presentation

If accepted for oral presentation, you will be offered an 8 minute presentation timeslot in a free paper session.

Electronic Poster Presentation or Display

If accepted for an e-poster presentation, you will be offered a 3 minute presentation timeslot and have the e-poster on display throughout the conference or choose to have your e-poster on display only.

E-posters in the categories “Case Studies”, “Post Market Surveillance” and “Professional Communication” are accepted for display only.

Languages: English or German. All abstracts must be presented in the language, it was submitted in.
Word limit: 275 words excl. title, authors and affiliations.
Template: Please use the abstract submission templates.
Review of abstracts: All abstracts are reviewed by the EWMA and DEWU Scientific Committees. Submission in a specific presentation type or category only indicates interest from the submitter's side. It is not a guarantee that it’s available. The Scientific Committee holds the right to offer the author another presentation type or category.
Abstract publication: By submitting an abstract to EWMA-DEWU 2026 submitters give their consent to the publication of the submitted abstract in the conference material (E.g. app, website, EWMA Journal of Wound Management).

Abstract submission templates

INTERNATIONAL ABSTRACT

SPANISH ABSTRACT

Abstract submission categories

Submit your abstract in one of these categories:

Acute Wounds
Antimicrobials
Atypical Wounds
Basic Science
Burns
Devices & Intervention
Diabetic Foot
Dressings
Education
e-Health

Health Economics & Outcome
Home Care
Infection
Leg Ulcer
Negative Pressure Wound Therapy
Nutrition
Pain
Pressure Ulcer
Prevention
Quality of life

Surgical approaches
Translational Science
Wound Assessment
Case Studies
(e-Poster on display only, no oral timeslot)
Post Market Surveillance
(e-Poster on display only, no oral timeslot)
Professional Communication
(e-Poster on display only, no oral timeslot)

Submission conditions

A. General Conditions

Abstracts are required for all oral presentations and e-posters.
Abstracts must be submitted by 4 December 2025, 23:59 CET.
Max. 6 abstracts with the same presenting author can be submitted.
Abstracts must be submitted in English or German.
Accepted abstracts may be published on the conference website, in the conference app and in the EWMA Journal of Wound Management Supplement. By submitting an abstract, you consent to giving EWMA permission to publish your abstract.
Withdrawal of abstracts can only be accepted if notified in writing and subsequently confirmed by the EWMA Secretariat. It is only possible to withdraw an abstract until 14 days after notification on acceptance.

B. Presenting Author and Registration

The presenting author must register as a participant for the full conference by the deadline informed in the acceptance e-mail.
Failure to register shall not be regarded as an automatic withdrawal of your abstract. Withdrawal of an abstract can only be made by writing to the EWMA Secretariat – see item A.6 above.
EWMA reserves the right to exclude any abstract from the scientific programme that is not followed by a participant registration.
Max. 2 oral presentations and max. 2 e-poster presentations by the same presenting author will be accepted for presentation at the conference. 
NB! The presenting author does not have to be the 1st author.

C. Contents of your abstract

The abstract word limit is max. 275 words per abstract excl. title, authors and affiliations. The EWMA Secretariat reserves the right to edit abstracts that exceed the word limit.
The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract.
The abstract must include the following:
Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
All abbreviations must be defined in first use. Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
Use of brand names: For all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. EWMA reserves the right to replace any brand name with a generic name without further notice.
Abstracts will not be accepted if previously presented at a EWMA conference unless there is a substantial increase in data.

D. Reviewing

The EWMA Scientific Committee will review the abstract.
Notification of acceptance or rejection of the abstract will be sent to the submitter in February 2026.
It is the responsibility of all submitters that all studies are performed with respect to national legislation, international legislation and ethical guidelines both with regards to humans and animals. The Scientific Committee reserves the right to reject any submitted abstract that is believed to violate these principles.
Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
The Scientific Committee reserves the right not to give detailed information as to why an abstract is rejected.

Questions regarding abstracts
For all enquiries regarding abstracts and speakers, please contact the EWMA Secretariat at scientific@ewma.org.

Awards & prizes

Interested to learn more about the EWMA-DEWU 2026 international awards and prizes, please click here.